HTEC
ROBO Global Healthcare Technology and Innovation ETF
The ROBO Global Healthcare Technology and Innovation ETF tracks a market-cap selected and weighted index of global healthcare technology companies.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 111.0 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Jun 24, 2019 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| GRAIL INC | 2.8 % |
| CAREDX, INC. | 2.5 % |
| NATERA INC | 2.4 % |
| TWIST BIOSCIENCE CORP. | 2.3 % |
| INTUITIVE SURGICAL INC | 2.2 % |
| MODERNA, INC. | 2.1 % |
| GLAUKOS CORP | 2.1 % |
| THERMO FISHER SCIENTIFIC INC | 2.1 % |
| GUARDANT HEALTH, INC. | 2.1 % |
| SIEMENS HEALTHINEERS AG | 2.0 % |
Constituent Breakdown
| Number of holdings | 65 |
| Herfindahl-Hirschman Index | 173 |
| Wgt avg mkt cap (mns) | $39,092 |
| Large cap (>$10bn) | 61.1% |
| Mid cap ($2-10bn) | 27.4% |
| Small cap (<$2bn) | 6.3% |
| Developed mkts. | 93.1% |
| Emerging mkts. | 1.6% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 74.8 % |
 |
SWITZERLAND | 5.4 % |
 |
BRITAIN | 4.0 % |
 |
GERMANY | 2.0 % |
 |
LUXEMBOURG | 1.9 % |
 |
NETHERLANDS | 1.8 % |
 |
CHINA | 1.6 % |
 |
ITALY | 1.2 % |
 |
JAPAN | 1.2 % |
 |
HONG KONG | 0.9 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 25.6% | 43.7% | 22.2% | 20.6% | -0.5% | -- | -- | 8.7% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | 25.6% | 43.7% | 22.2% | 20.6% | -0.5% | -- | -- | 8.7% | Ann. Volatility | 23.4% | 22.2% | 23.0% | 21.9% | 24.9% | -- | -- | 25.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.86 | 25% |
| MSCI EAFE | 0.72 | 26% |
| MSCI Emg Mkts | 0.31 | 12% |
Liquidity Measures
| Avg. volume (000) | 82 |
| ADV traded (mns) | $4 |
| Turnover | 3.3% |
| Avg. Bid/Ask (% of price) | 0.17% |
Technical Indicators
| 30d moving avg. (EMA) | $44.07 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 0.75/0.61 |
| Bollinger Bands (Upper/Lower) | $46.62/$41.57 |
| Short interest (% of AUM) | 0.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HTEC |
Expenses vs. HTEC |
ALTAR Score™ vs. HTEC |
|---|---|---|---|---|
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 32.2% | -40 bp | +5.0% |
| MDEV | First Trust Indxx Medical Devices ETF | 30.0% | -10 bp | +3.4% |
| HELX | Franklin Genomic Advancements ETF | 29.8% | -30 bp | -2.6% |
| GNMX | Corgi Genomics & Precision Medicine ETF | 28.0% | -45 bp | -3.6% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 26.6% | -45 bp | +0.0% |
| FXH | First Trust Health Care AlphaDEX Fund | 26.5% | -19 bp | +4.0% |
| IYH | iShares U.S. Healthcare ETF | 24.1% | -43 bp | +4.1% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 24.0% | -15 bp | -1.5% |
| GNOM | Global X Genomics & Biotechnology ETF | 23.2% | -30 bp | -3.5% |
| VHT | Vanguard Health Care ETF | 23.0% | -71 bp | +3.5% |
Risk and Returns: HTEC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
1.2%
ALTAR SCORE™
9th
PERCENTILE
AVOID
ETFRC RATING
There are 746 funds in the Global Equity category with an average
ALTAR Score™ of 4.8% and a standard deviation
of 2.6%. HTEC's ALTAR Score™ is approximately -1.3 standard
deviations above the category average. This places HTEC in the 9th percentile
among funds in the category.
Sell-Side Consensus
$52.06
PRICE TARGET
+15.7%
UPSIDE